Structure TherapeuticsGPCR

那斯達克 · USD
42.71
+2.33
(+5.77%)
盤中 09/10 12:26 (UTC+8)
09/10 12:26 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
118,63089,379-13,74073,78770,45156,31147,06145,836-32,015
研發費用
100,05766,50768,68958,98954,71042,86733,48732,59822,05020,679
推銷及管理費用
18,57322,872-82,42914,79815,74113,44413,57413,23811,26611,336
非經常性項目費用
----------
其他營業費用
----------
營業利益
-118,630
-89,379
13,740
-73,787
-70,451
-56,311
-47,061
-45,836
-33,316
-32,015
其他收入及費用
12,70513,60119,4348,1838,9299,57610,71811,9517,335-
利息費用
----------
稅前純益
-105,925
-75,778
33,174
-65,604
-61,522
-46,735
-36,343
-33,885
-25,981
-26,007
所得稅
23419017010813998136925329
稅後純益
-106,159
-75,968
33,004
-65,712
-61,661
-46,833
-36,479
-33,977
-26,034
-26,036
基本每股稅後盈餘(元)
-1.47-1.050.47-1.11-1.07-0.81-0.64-0.60-0.54-0.57
稀釋每股稅後盈餘(元)
-0.49-0.350.20-0.37-0.36-0.27-0.22-0.20-0.17-0.19
基本平均股數(千股)
72652.0072442.0070837.0058489.0057566.0057350.0057286.0057210.0049413.0046570.00
稀釋平均股數(千股)
72652.0072442.0070837.0058489.0057566.0057350.0057286.0057210.0049413.0046570.00
還原基本每股稅後盈餘(元)
-1.47-1.050.47-1.11-1.07-0.81-0.64-0.60-0.54-0.57
還原稀釋每股稅後盈餘(元)
-0.49-0.350.20-0.37-0.36-0.27-0.22-0.20-0.17-0.19
還原基本平均股數(千股)
72,65272,44270,83758,48957,56657,35057,28657,21049,41346,570
還原稀釋平均股數(千股)
72,65272,44270,83758,48957,56657,35057,28657,21049,41346,570
EBITDA(千元)
-108,747-78,43831,149-68,516-65,571-51,658-42,102-39,588-28,933-29,062

大家都在看

HOT